Results 211 to 220 of about 10,054 (222)

Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence

Expert Opinion on Biological Therapy, 2018
Jonathan A Bernstein, Abhishek Kavati, Michael D Tharp   +2 more
exaly  

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Ragip Ertaş, Mustafa Atasoy, Tomasz Hawro   +2 more
exaly  

Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients

Pediatric Allergy and Immunology, 2018
Maria-Magdalena Balp, Karsten Weller, Charis Papavassilis   +2 more
exaly  

Evaluation of a Guidelines-Based Approach to the Treatment of Chronic Spontaneous Urticaria

Journal of Allergy and Clinical Immunology: in Practice, 2018
, Josefina Zakzuk, Ricardo Cardona
exaly  

Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

Allergy: European Journal of Allergy and Clinical Immunology, 2019
N Schoepke, Riccardo Asero, Marta Ferrer   +2 more
exaly  

Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practice

Expert Opinion on Biological Therapy, 2013
Moises Labrador-Horrillo, Antonio Valero, Ignacio Jáuregui   +2 more
exaly  

Treating chronic spontaneous urticaria in children

The Journal of Allergy and Clinical Immunology: In Practice, 2018
openaire   +2 more sources

Chronic spontaneous urticaria and internal parasites – a systematic review

Allergy: European Journal of Allergy and Clinical Immunology, 2016
Pavel Kolkhir, Galina Balakirski, H F Merk   +2 more
exaly  

Endotypes of chronic spontaneous urticaria in children

Journal of Allergy and Clinical Immunology
Cristiana Indolfi, Angela Klain, Alessandra Perrotta, Giulio Dinardo, Carolina Grella, Michele Miraglia del Giudice   +5 more
openaire   +2 more sources

Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety

Expert Opinion on Biological Therapy, 2017
exaly